SCHEMBL7297979

SCHEMBL7297979

CCC(C)(Cc1ccc(OC)cc1)NCCCC(=O)N1CCC(C(=O)N(C)C)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKAB2 O43741 1/20 0.41
PRKAG1 P54619 1/20 0.41
PRKAA2 P54646 1/20 0.41
PRKAA1 Q13131 1/20 0.41
PRKAG3 Q9UGI9 1/20 0.41
PRKAG2 Q9UGJ0 1/20 0.41
PRKAB1 Q9Y478 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
TSHR P16473 2/20 0.40
KMT2A Q03164 2/20 0.40
ALDH1A1 P00352 1/20 0.40
EPHX2 P34913 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.39
POLB P06746 3/20 0.39
FKBP1A P62942 1/20 0.39
LMNA P02545 1/20 0.39
MEN1 O00255 1/20 0.39
RXFP1 Q9HBX9 1/20 0.38
CACNA1G O43497 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Idaverine SCHEMBL180957 0.74 TSHR (0.46) NPC1RAB9ATSHRKMT2AALDH1A1
Idaverine SCHEMBL7286939 0.74 TSHR (0.46) NPC1RAB9ATSHRKMT2AALDH1A1
Idaverine SCHEMBL10340527 0.73 CYP3A4 (0.47) NPC1RAB9ATSHRKMT2AALDH1A1
SCHEMBL10483364 0.67 CYP3A4 (0.36) NPC1RAB9ATSHRKMT2AALDH1A1
SCHEMBL10483360 0.67 CYP3A4 (0.36) NPC1RAB9ATSHRKMT2AALDH1A1
SCHEMBL10868814 0.67 TSHR (0.45) NPC1RAB9ATSHRKMT2AALDH1A1
SCHEMBL10483403 0.67 CYP3A4 (0.46) NPC1RAB9ATSHRKMT2AALDH1A1
SCHEMBL10483375 0.66 DRD2 (0.52) EPHX2ACHE
SCHEMBL10483516 0.66 POLB (0.43) TSHRALDH1A1SMN1; SMN2POLBLMNA
SCHEMBL10483388 0.66 EPHX2 (0.41) NPC1RAB9ATSHRKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0402733-A2 Agent for the treatment of central nervous system illnesses and for the enhancement of cerebral blood flow Dr. Karl Thomae GmbH (DE) 1990-12-19 EP claimed
EP-0324348-A2 Derivatives of piperidincarboxamide for the treatment of Bradycardia and Bradyarrhythmia Dr. Karl Thomae GmbH (DE) 1989-07-19 EP claimed